TapewireFind a company

person · Reporting owner

Ma-Weaver Jacob

Disclosed activity across 5 companies

Tapewire entity
74016
SEC CIK
0001922140

Export transaction history ↓

Reported relationships

Latest disclosed role at each company.

CompanyLast reported asReport datePublished
Lite Strategy, Inc.MEIP · Entity 739610% ownerOctober 20, 2023October 24, 2023
Nabors Energy Transition Corp. IINETD · Entity 73307See Footnote 1October 16, 2025October 23, 2025
Quantum FinTech Acquisition CorpQFTA · Entity 9408610% ownerFebruary 06, 2023February 13, 2023
SYNLOGIC, INC.SYBX · Entity 7801See footnote 1February 09, 2024February 16, 2024

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

Lite Strategy, Inc.

Report date October 20, 2023 · Filed October 24, 2023

Jointly reported with Funicular Funds, LP, Cable Car Capital, LP

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Common StockSEC Table I · non-derivativeIndirectBy Funicular Funds, LP611,440 Reported balance After 2023-10-20 transaction · row 1 Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source row

Row 1 · 2023-10-20 · Other · Acquired 120,600 · Balance 611,440

F1: The securities were purchased and are held by Funicular Funds, LP (the "Fund"). Cable Car Capital LLC ("Cable Car"), as the General Partner of the Fund, and Jacob Ma-Weaver, as the Managing Member of Cable Car, may each be deemed the beneficial owner of the shares owned by the Fund. Each of the Reporting Persons is a member of a Section 13(d) group that collectively owns more than 10% of the Issuer's outstanding shares of Common Stock. Each of the Reporting Persons disclaims beneficial ownership of the securities reported herein except to the extent of his or its pecuniary interest therein.

Put Option (obligation to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $7.00 · Expires 2023-10-20IndirectBy Funicular Funds, LP4,494 Reported balance After 2023-10-20 transaction · row 2 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 2 · 2023-10-20 · Other · Disposed 1,206 · Balance 4,494

F1: The securities were purchased and are held by Funicular Funds, LP (the "Fund"). Cable Car Capital LLC ("Cable Car"), as the General Partner of the Fund, and Jacob Ma-Weaver, as the Managing Member of Cable Car, may each be deemed the beneficial owner of the shares owned by the Fund. Each of the Reporting Persons is a member of a Section 13(d) group that collectively owns more than 10% of the Issuer's outstanding shares of Common Stock. Each of the Reporting Persons disclaims beneficial ownership of the securities reported herein except to the extent of his or its pecuniary interest therein.

Put Option (obligation to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $7.00 · Expires 2023-10-20IndirectBy Funicular Funds, LP0 Reported balance After 2023-10-20 transaction · row 3 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 3 · 2023-10-20 · Other · Disposed 4,494 · Balance 0

F1: The securities were purchased and are held by Funicular Funds, LP (the "Fund"). Cable Car Capital LLC ("Cable Car"), as the General Partner of the Fund, and Jacob Ma-Weaver, as the Managing Member of Cable Car, may each be deemed the beneficial owner of the shares owned by the Fund. Each of the Reporting Persons is a member of a Section 13(d) group that collectively owns more than 10% of the Issuer's outstanding shares of Common Stock. Each of the Reporting Persons disclaims beneficial ownership of the securities reported herein except to the extent of his or its pecuniary interest therein.

Filing footnotes · ownership attribution and instrument terms

F1: The securities were purchased and are held by Funicular Funds, LP (the "Fund"). Cable Car Capital LLC ("Cable Car"), as the General Partner of the Fund, and Jacob Ma-Weaver, as the Managing Member of Cable Car, may each be deemed the beneficial owner of the shares owned by the Fund. Each of the Reporting Persons is a member of a Section 13(d) group that collectively owns more than 10% of the Issuer's outstanding shares of Common Stock. Each of the Reporting Persons disclaims beneficial ownership of the securities reported herein except to the extent of his or its pecuniary interest therein.

Nabors Energy Transition Corp. II

Report date October 16, 2025 · Filed October 23, 2025

Jointly reported with Funicular Funds, LP, Cable Car Capital, LP

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Class A Ordinary Shares, $0.0001 par valueSEC Table I · non-derivativeDirect1,875,115 Reported balance Holding disclosure · report date 2025-10-16 · row 1 Holding and transaction disclosures are not merged.
1 source row

Row 1 · Balance 1,875,115

Quantum FinTech Acquisition Corp

Report date February 06, 2023 · Filed February 13, 2023

Jointly reported with Funicular Funds, LP, Cable Car Capital, LP

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Common stockSEC Table I · non-derivativeDirect2,351,800 Reported balance Holding disclosure · report date 2023-02-06 · row 1 Holding and transaction disclosures are not merged.
1 source row

Row 1 · Balance 2,351,800

SYNLOGIC, INC.

Report date February 09, 2024 · Filed February 16, 2024

Jointly reported with Funicular Funds, LP, Cable Car Capital, LP

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Common stockSEC Table I · non-derivativeDirect3,312,219 Reported balance Holding disclosure · report date 2024-02-09 · row 1 Holding and transaction disclosures are not merged.
1 source row

Row 1 · Balance 3,312,219

F1: This Form 3 is being filed by Funicular Funds, LP (the "Fund"), its general partner Cable Car Capital LLC ("Cable Car"), and Jacob Ma-Weaver, the Managing Member of Cable Car. The Fund, Cable Car, and Mr. Ma-Weaver may be deemed to be members of a Section 13(d) group that may be deemed to beneficially own more than 10% of the Issuer's outstanding shares of Common Stock. Each of the Reporting Persons disclaims beneficial ownership of the securities reported herein except to the extent of his or its pecuniary interest therein.

Filing footnotes · ownership attribution and instrument terms

F1: This Form 3 is being filed by Funicular Funds, LP (the "Fund"), its general partner Cable Car Capital LLC ("Cable Car"), and Jacob Ma-Weaver, the Managing Member of Cable Car. The Fund, Cable Car, and Mr. Ma-Weaver may be deemed to be members of a Section 13(d) group that may be deemed to beneficially own more than 10% of the Issuer's outstanding shares of Common Stock. Each of the Reporting Persons disclaims beneficial ownership of the securities reported herein except to the extent of his or its pecuniary interest therein.

Past disclosures · reporting ended (1)

No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.

Oruka Therapeutics, Inc.

Report date August 29, 2024 · Filed August 30, 2024

Section 16 reporting ended · disclosed 2024-08-30. Current position is not established by this disclosure.

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Stock option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $1.64 · Expires 2034-01-30Direct0 Reported balance After 2024-08-29 transaction · row 1 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 1 · 2024-08-29 · Other · Disposed 6,000 · Balance 0

F1: This Form 4 is filed by Jacob Ma-Weaver. Mr. Ma-Weaver, Funicular Funds, LP, and Cable Car Capital LLC may have been deemed to be members of a Section 13(d) group that may have been deemed to collectively beneficially own more than 10% of the Issuer's outstanding shares of Common Stock. Each of the Reporting Persons disclaims beneficial ownership of the securities reported herein except to the extent of his or its pecuniary interest therein. Following the closing of the Issuer's business combination on August 29, 2024, the Reporting Person is no longer a Director of the Issuer and the group no longer holds more than 10% of its outstanding shares of Common Stock.

F2: Pursuant to the terms of the Issuer's business combination agreement, all outstanding Issuer incentive options were canceled, and the holders thereof received an amount in cash equal to the product obtained by multiplying (A) the excess of approximately $3.9489 over the exercise price per share of the Parent Common Stock underlying such Parent Option by (B) the number of shares of the Parent Common Stock underlying such Parent Option.

F3: The Reporting Person assigned the proceeds of the option cash-out transactions to Funicular Funds, LP.

Stock option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $2.32 · Expires 2032-12-15Direct0 Reported balance After 2024-08-29 transaction · row 2 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 2 · 2024-08-29 · Other · Disposed 6,000 · Balance 0

F2: Pursuant to the terms of the Issuer's business combination agreement, all outstanding Issuer incentive options were canceled, and the holders thereof received an amount in cash equal to the product obtained by multiplying (A) the excess of approximately $3.9489 over the exercise price per share of the Parent Common Stock underlying such Parent Option by (B) the number of shares of the Parent Common Stock underlying such Parent Option.

F3: The Reporting Person assigned the proceeds of the option cash-out transactions to Funicular Funds, LP.

Stock option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $2.27 · Expires 2032-06-15Direct0 Reported balance After 2024-08-29 transaction · row 3 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 3 · 2024-08-29 · Other · Disposed 12,000 · Balance 0

F2: Pursuant to the terms of the Issuer's business combination agreement, all outstanding Issuer incentive options were canceled, and the holders thereof received an amount in cash equal to the product obtained by multiplying (A) the excess of approximately $3.9489 over the exercise price per share of the Parent Common Stock underlying such Parent Option by (B) the number of shares of the Parent Common Stock underlying such Parent Option.

F3: The Reporting Person assigned the proceeds of the option cash-out transactions to Funicular Funds, LP.

Filing footnotes · ownership attribution and instrument terms

F1: This Form 4 is filed by Jacob Ma-Weaver. Mr. Ma-Weaver, Funicular Funds, LP, and Cable Car Capital LLC may have been deemed to be members of a Section 13(d) group that may have been deemed to collectively beneficially own more than 10% of the Issuer's outstanding shares of Common Stock. Each of the Reporting Persons disclaims beneficial ownership of the securities reported herein except to the extent of his or its pecuniary interest therein. Following the closing of the Issuer's business combination on August 29, 2024, the Reporting Person is no longer a Director of the Issuer and the group no longer holds more than 10% of its outstanding shares of Common Stock.

F2: Pursuant to the terms of the Issuer's business combination agreement, all outstanding Issuer incentive options were canceled, and the holders thereof received an amount in cash equal to the product obtained by multiplying (A) the excess of approximately $3.9489 over the exercise price per share of the Parent Common Stock underlying such Parent Option by (B) the number of shares of the Parent Common Stock underlying such Parent Option.

F3: The Reporting Person assigned the proceeds of the option cash-out transactions to Funicular Funds, LP.

Transaction history

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateCompanyActivity / securityShares / unitsReported priceReported valueDetails
August 29, 2024 Filed Aug 30, 2024 21:57 UTC Oruka Therapeutics, Inc. ABIO · Entity 3781 OtherStock option (right to buy) · Derivative 12,000 Not disclosed Strike: $2.27 Not disclosed
Disclosure

SEC source: 0001937147-24-000007 · primary_doc.xml · derivative · entry 3

Ma-Weaver Jacob · CIK 0001922140 · See footnote 1

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common stock · Not disclosed shares

Expires 2032-06-15

F2 · kind: Pursuant to the terms of the Issuer's business combination agreement, all outstanding Issuer incentive options were canceled, and the holders thereof received an amount in cash equal to the product obtained by multiplying (A) the excess of approximately $3.9489 over the exercise price per share of the Parent Common Stock underlying such Parent Option by (B) the number of shares of the Parent Common Stock underlying such Parent Option.

F2 · price: Pursuant to the terms of the Issuer's business combination agreement, all outstanding Issuer incentive options were canceled, and the holders thereof received an amount in cash equal to the product obtained by multiplying (A) the excess of approximately $3.9489 over the exercise price per share of the Parent Common Stock underlying such Parent Option by (B) the number of shares of the Parent Common Stock underlying such Parent Option.

F2 · derivative.exercise_date: Pursuant to the terms of the Issuer's business combination agreement, all outstanding Issuer incentive options were canceled, and the holders thereof received an amount in cash equal to the product obtained by multiplying (A) the excess of approximately $3.9489 over the exercise price per share of the Parent Common Stock underlying such Parent Option by (B) the number of shares of the Parent Common Stock underlying such Parent Option.

F3 · underlyingValue: The Reporting Person assigned the proceeds of the option cash-out transactions to Funicular Funds, LP.

Read SEC document
August 29, 2024 Filed Aug 30, 2024 21:57 UTC Oruka Therapeutics, Inc. ABIO · Entity 3781 OtherStock option (right to buy) · Derivative 6,000 Not disclosed Strike: $2.32 Not disclosed
Disclosure

SEC source: 0001937147-24-000007 · primary_doc.xml · derivative · entry 2

Ma-Weaver Jacob · CIK 0001922140 · See footnote 1

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common stock · Not disclosed shares

Expires 2032-12-15

F2 · kind: Pursuant to the terms of the Issuer's business combination agreement, all outstanding Issuer incentive options were canceled, and the holders thereof received an amount in cash equal to the product obtained by multiplying (A) the excess of approximately $3.9489 over the exercise price per share of the Parent Common Stock underlying such Parent Option by (B) the number of shares of the Parent Common Stock underlying such Parent Option.

F2 · price: Pursuant to the terms of the Issuer's business combination agreement, all outstanding Issuer incentive options were canceled, and the holders thereof received an amount in cash equal to the product obtained by multiplying (A) the excess of approximately $3.9489 over the exercise price per share of the Parent Common Stock underlying such Parent Option by (B) the number of shares of the Parent Common Stock underlying such Parent Option.

F2 · derivative.exercise_date: Pursuant to the terms of the Issuer's business combination agreement, all outstanding Issuer incentive options were canceled, and the holders thereof received an amount in cash equal to the product obtained by multiplying (A) the excess of approximately $3.9489 over the exercise price per share of the Parent Common Stock underlying such Parent Option by (B) the number of shares of the Parent Common Stock underlying such Parent Option.

F3 · underlyingValue: The Reporting Person assigned the proceeds of the option cash-out transactions to Funicular Funds, LP.

Read SEC document
August 29, 2024 Filed Aug 30, 2024 21:57 UTC Oruka Therapeutics, Inc. ABIO · Entity 3781 OtherStock option (right to buy) · Derivative 6,000 Not disclosed Strike: $1.64 Not disclosed
Disclosure

SEC source: 0001937147-24-000007 · primary_doc.xml · derivative · entry 1

Ma-Weaver Jacob · CIK 0001922140 · See footnote 1

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common stock · Not disclosed shares

Expires 2034-01-30

F1 · security: This Form 4 is filed by Jacob Ma-Weaver. Mr. Ma-Weaver, Funicular Funds, LP, and Cable Car Capital LLC may have been deemed to be members of a Section 13(d) group that may have been deemed to collectively beneficially own more than 10% of the Issuer's outstanding shares of Common Stock. Each of the Reporting Persons disclaims beneficial ownership of the securities reported herein except to the extent of his or its pecuniary interest therein. Following the closing of the Issuer's business combination on August 29, 2024, the Reporting Person is no longer a Director of the Issuer and the group no longer holds more than 10% of its outstanding shares of Common Stock.

F2 · kind: Pursuant to the terms of the Issuer's business combination agreement, all outstanding Issuer incentive options were canceled, and the holders thereof received an amount in cash equal to the product obtained by multiplying (A) the excess of approximately $3.9489 over the exercise price per share of the Parent Common Stock underlying such Parent Option by (B) the number of shares of the Parent Common Stock underlying such Parent Option.

F2 · price: Pursuant to the terms of the Issuer's business combination agreement, all outstanding Issuer incentive options were canceled, and the holders thereof received an amount in cash equal to the product obtained by multiplying (A) the excess of approximately $3.9489 over the exercise price per share of the Parent Common Stock underlying such Parent Option by (B) the number of shares of the Parent Common Stock underlying such Parent Option.

F2 · derivative.exercise_date: Pursuant to the terms of the Issuer's business combination agreement, all outstanding Issuer incentive options were canceled, and the holders thereof received an amount in cash equal to the product obtained by multiplying (A) the excess of approximately $3.9489 over the exercise price per share of the Parent Common Stock underlying such Parent Option by (B) the number of shares of the Parent Common Stock underlying such Parent Option.

F3 · underlyingValue: The Reporting Person assigned the proceeds of the option cash-out transactions to Funicular Funds, LP.

Read SEC document
January 30, 2024 Filed Jan 31, 2024 23:39 UTC Oruka Therapeutics, Inc. ABIO · Entity 3781 GrantStock option (right to buy) · Derivative 6,000 $0.00 Strike: $1.64 $0.00
Disclosure

SEC source: 0001922140-24-000001 · primary_doc.xml · derivative · entry 1

Ma-Weaver Jacob · CIK 0001922140 · Director · 10% owner · See footnote 1

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,000

Underlying: Common stock · 6,000 shares

Expires 2034-01-30

F1 · security: This Form 4 is filed by Jacob Ma-Weaver. Mr. Ma-Weaver, Funicular Funds, LP, and Cable Car Capital LLC may be deemed to be members of a Section 13(d) group that may be deemed to collectively beneficially own more than 10% of the Issuer's outstanding shares of Common Stock. Each of the Reporting Persons disclaims beneficial ownership of the securities reported herein except to the extent of his or its pecuniary interest therein.

F2 · derivative.exercise_date: Grant to the Reporting Person of a stock option under the 2020 Equity Incentive Plan, vesting in 12 equal monthly installments beginning as of January 30, 2024, subject to the Reporting Person continuing to provide Continuous Service (as defined in the 2020 Equity Incentive Plan) through such date. If the Reporting Person's service as a director of the Issuer terminates in connection with or at any time following a change in control (for whatever reason), then any unexpired options that remain unvested shall become fully vested.

Read SEC document
October 20, 2023 Filed Oct 24, 2023 23:34 UTC Lite Strategy, Inc. MEIP · Entity 7396 OtherPut Option (obligation to buy) · Derivative 4,494 $0.00 Strike: $7.00 $0.00
Disclosure

SEC source: 0000921895-23-002375 · form413392004fun_10242023.xml · derivative · entry 3

Funicular Funds, LP · CIK 0001937147 · 10% owner

Cable Car Capital LLC · CIK 0001699575 · 10% owner

Ma-Weaver Jacob · CIK 0001922140 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Indirect · By Funicular Funds, LP

Disclosed balance after: 0

Underlying: Common Stock · 449,400 shares

Expires 2023-10-20

F1 · ownership.nature: The securities were purchased and are held by Funicular Funds, LP (the "Fund"). Cable Car Capital LLC ("Cable Car"), as the General Partner of the Fund, and Jacob Ma-Weaver, as the Managing Member of Cable Car, may each be deemed the beneficial owner of the shares owned by the Fund. Each of the Reporting Persons is a member of a Section 13(d) group that collectively owns more than 10% of the Issuer's outstanding shares of Common Stock. Each of the Reporting Persons disclaims beneficial ownership of the securities reported herein except to the extent of his or its pecuniary interest therein.

Read SEC document
October 20, 2023 Filed Oct 24, 2023 23:34 UTC Lite Strategy, Inc. MEIP · Entity 7396 OtherPut Option (obligation to buy) · Derivative 1,206 $0.00 Strike: $7.00 $0.00
Disclosure

SEC source: 0000921895-23-002375 · form413392004fun_10242023.xml · derivative · entry 2

Funicular Funds, LP · CIK 0001937147 · 10% owner

Cable Car Capital LLC · CIK 0001699575 · 10% owner

Ma-Weaver Jacob · CIK 0001922140 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Indirect · By Funicular Funds, LP

Disclosed balance after: 4,494

Underlying: Common Stock · 120,600 shares

Expires 2023-10-20

F1 · ownership.nature: The securities were purchased and are held by Funicular Funds, LP (the "Fund"). Cable Car Capital LLC ("Cable Car"), as the General Partner of the Fund, and Jacob Ma-Weaver, as the Managing Member of Cable Car, may each be deemed the beneficial owner of the shares owned by the Fund. Each of the Reporting Persons is a member of a Section 13(d) group that collectively owns more than 10% of the Issuer's outstanding shares of Common Stock. Each of the Reporting Persons disclaims beneficial ownership of the securities reported herein except to the extent of his or its pecuniary interest therein.

Read SEC document
October 20, 2023 Filed Oct 24, 2023 23:34 UTC Lite Strategy, Inc. MEIP · Entity 7396 OtherCommon Stock 120,600 $7.00 $844,200.00
Disclosure

SEC source: 0000921895-23-002375 · form413392004fun_10242023.xml · nonDerivative · entry 1

Funicular Funds, LP · CIK 0001937147 · 10% owner

Cable Car Capital LLC · CIK 0001699575 · 10% owner

Ma-Weaver Jacob · CIK 0001922140 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Indirect · By Funicular Funds, LP

Disclosed balance after: 611,440

F1 · ownership.nature: The securities were purchased and are held by Funicular Funds, LP (the "Fund"). Cable Car Capital LLC ("Cable Car"), as the General Partner of the Fund, and Jacob Ma-Weaver, as the Managing Member of Cable Car, may each be deemed the beneficial owner of the shares owned by the Fund. Each of the Reporting Persons is a member of a Section 13(d) group that collectively owns more than 10% of the Issuer's outstanding shares of Common Stock. Each of the Reporting Persons disclaims beneficial ownership of the securities reported herein except to the extent of his or its pecuniary interest therein.

Read SEC document
October 11, 2023 Filed Oct 13, 2023 21:04 UTC Lite Strategy, Inc. MEIP · Entity 7396 OtherPut Option (obligation to buy) · Derivative 300 $0.00 Strike: $7.00 $0.00
Disclosure

SEC source: 0000921895-23-002340 · form413392004fun_10132023.xml · derivative · entry 2

Funicular Funds, LP · CIK 0001937147 · 10% owner

Cable Car Capital LLC · CIK 0001699575 · 10% owner

Ma-Weaver Jacob · CIK 0001922140 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Indirect · By Funicular Funds, LP

Disclosed balance after: 5,700

Underlying: Common Stock · 30,000 shares

Expires 2023-10-20

F1 · ownership.nature: The securities were purchased and are held by Funicular Funds, LP (the "Fund"). Cable Car Capital LLC ("Cable Car"), as the General Partner of the Fund, and Jacob Ma-Weaver, as the Managing Member of Cable Car, may each be deemed the beneficial owner of the shares owned by the Fund. Each of the Reporting Persons is a member of a Section 13(d) group that collectively owns more than 10% of the Issuer's outstanding shares of Common Stock. Each of the Reporting Persons disclaims beneficial ownership of the securities reported herein except to the extent of his or its pecuniary interest therein.

Read SEC document
October 11, 2023 Filed Oct 13, 2023 21:04 UTC Lite Strategy, Inc. MEIP · Entity 7396 OtherCommon Stock 30,000 $7.00 $210,000.00
Disclosure

SEC source: 0000921895-23-002340 · form413392004fun_10132023.xml · nonDerivative · entry 1

Funicular Funds, LP · CIK 0001937147 · 10% owner

Cable Car Capital LLC · CIK 0001699575 · 10% owner

Ma-Weaver Jacob · CIK 0001922140 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Indirect · By Funicular Funds, LP

Disclosed balance after: 490,840

F1 · ownership.nature: The securities were purchased and are held by Funicular Funds, LP (the "Fund"). Cable Car Capital LLC ("Cable Car"), as the General Partner of the Fund, and Jacob Ma-Weaver, as the Managing Member of Cable Car, may each be deemed the beneficial owner of the shares owned by the Fund. Each of the Reporting Persons is a member of a Section 13(d) group that collectively owns more than 10% of the Issuer's outstanding shares of Common Stock. Each of the Reporting Persons disclaims beneficial ownership of the securities reported herein except to the extent of his or its pecuniary interest therein.

Read SEC document
September 22, 2023 Filed Sep 25, 2023 23:41 UTC Lite Strategy, Inc. MEIP · Entity 7396 SalePut Option (obligation to buy) · Derivative 6,000 $0.14 Strike: $7.00 $869.40
Disclosure

SEC source: 0000921895-23-002231 · form413392004fun_09252023.xml · derivative · entry 2

Funicular Funds, LP · CIK 0001937147 · 10% owner

Cable Car Capital LLC · CIK 0001699575 · 10% owner

Ma-Weaver Jacob · CIK 0001922140 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Indirect · By Funicular Funds, LP

Disclosed balance after: 6,000

Underlying: Common Stock · 600,000 shares

Expires 2023-10-20

F1 · ownership.nature: The securities were purchased and are held by Funicular Funds, LP (the "Fund"). Cable Car Capital LLC ("Cable Car"), as the General Partner of the Fund, and Jacob Ma-Weaver, as the Managing Member of Cable Car, may each be deemed the beneficial owner of the shares owned by the Fund. Each of the Reporting Persons is a member of a Section 13(d) group that collectively owns more than 10% of the Issuer's outstanding shares of Common Stock. Each of the Reporting Persons disclaims beneficial ownership of the securities reported herein except to the extent of his or its pecuniary interest therein.

Read SEC document
September 22, 2023 Filed Sep 25, 2023 23:41 UTC Lite Strategy, Inc. MEIP · Entity 7396 PurchaseCommon Stock 32,040 $6.85 $219,554.10
Disclosure

SEC source: 0000921895-23-002231 · form413392004fun_09252023.xml · nonDerivative · entry 1

Funicular Funds, LP · CIK 0001937147 · 10% owner

Cable Car Capital LLC · CIK 0001699575 · 10% owner

Ma-Weaver Jacob · CIK 0001922140 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Indirect · By Funicular Funds, LP

Disclosed balance after: 460,840

F1 · ownership.nature: The securities were purchased and are held by Funicular Funds, LP (the "Fund"). Cable Car Capital LLC ("Cable Car"), as the General Partner of the Fund, and Jacob Ma-Weaver, as the Managing Member of Cable Car, may each be deemed the beneficial owner of the shares owned by the Fund. Each of the Reporting Persons is a member of a Section 13(d) group that collectively owns more than 10% of the Issuer's outstanding shares of Common Stock. Each of the Reporting Persons disclaims beneficial ownership of the securities reported herein except to the extent of his or its pecuniary interest therein.

Read SEC document
September 21, 2023 Filed Sep 23, 2023 01:19 UTC Lite Strategy, Inc. MEIP · Entity 7396 PurchaseCommon Stock 22,400 $6.46 $144,739.84
Disclosure

SEC source: 0001193805-23-001316 · e618956_4-meipharm.xml · nonDerivative · entry 2

Funicular Funds, LP · CIK 0001937147 · 10% owner

Cable Car Capital LLC · CIK 0001699575 · 10% owner

Ma-Weaver Jacob · CIK 0001922140 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Indirect · By Funicular Funds, LP

Disclosed balance after: 428,800

F1 · ownership.nature: The securities were purchased and are held by Funicular Funds, LP (the "Fund"). Cable Car Capital LLC ("Cable Car"), as the General Partner of the Fund, and Jacob Ma-Weaver, as the Managing Member of Cable Car, may each be deemed the beneficial owner of the shares owned by the Fund. Each of the Reporting Persons is a member of a Section 13(d) group that collectively owns more than 10% of the Issuer's outstanding shares of Common Stock. Each of the Reporting Persons disclaims beneficial ownership of the securities reported herein except to the extent of his or its pecuniary interest therein.

Read SEC document
September 20, 2023 Filed Sep 23, 2023 01:19 UTC Lite Strategy, Inc. MEIP · Entity 7396 PurchaseCommon Stock 80,000 $6.01 $480,744.00
Disclosure

SEC source: 0001193805-23-001316 · e618956_4-meipharm.xml · nonDerivative · entry 1

Funicular Funds, LP · CIK 0001937147 · 10% owner

Cable Car Capital LLC · CIK 0001699575 · 10% owner

Ma-Weaver Jacob · CIK 0001922140 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Indirect · By Funicular Funds, LP

Disclosed balance after: 406,400

F1 · ownership.nature: The securities were purchased and are held by Funicular Funds, LP (the "Fund"). Cable Car Capital LLC ("Cable Car"), as the General Partner of the Fund, and Jacob Ma-Weaver, as the Managing Member of Cable Car, may each be deemed the beneficial owner of the shares owned by the Fund. Each of the Reporting Persons is a member of a Section 13(d) group that collectively owns more than 10% of the Issuer's outstanding shares of Common Stock. Each of the Reporting Persons disclaims beneficial ownership of the securities reported herein except to the extent of his or its pecuniary interest therein.

Read SEC document
December 16, 2022 Filed Dec 19, 2022 22:33 UTC Oruka Therapeutics, Inc. ABIO · Entity 3781 OtherPut Option · Derivative 300 $0.00 Strike: $2.50 $0.00
Disclosure

SEC source: 0000921895-22-003245 · form413392002_12192022.xml · derivative · entry 4

Funicular Funds, LP · CIK 0001937147 · 10% owner · See Footnote 1

Ma-Weaver Jacob · CIK 0001922140 · Director · 10% owner · See Footnote 1

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 30,000 shares

Expires 2022-12-16

F1 · security: This Form 4 is filed by Funicular Funds, LP (the "Fund") and Jacob Ma-Weaver ("Mr. Ma-Weaver" and together with the Fund, the "Reporting Persons"). The Reporting Persons, the Funicular Fund ("Funicular") and Cable Car Capital LLC ("Cable Car") may be deemed to be a member of a Section 13(d) group that may be deemed to collectively beneficially own more than 10% of the Issuer's outstanding shares of Common Stock. The Reporting Persons, Funicular and Cable Car disclaim beneficial ownership of the securities reported herein except to the extent of his or its pecuniary interest therein.

F2 · ownership.direct: Represents securities directly owned by the Fund. Funicular, as a feeder fund to the Fund, may be deemed to beneficially own the securities directly ownedby the Fund. Cable Car, as the general partner of the Fund, may be deemed to beneficially own the securities directly owned by the Fund. Mr. Ma-Weaver, asthe Managing Member of Cable Car, may be deemed to beneficially own the securities directly owned by the Fund.

Read SEC document
December 16, 2022 Filed Dec 19, 2022 22:33 UTC Oruka Therapeutics, Inc. ABIO · Entity 3781 OtherPut Option · Derivative 14,200 $0.00 Strike: $2.50 $0.00
Disclosure

SEC source: 0000921895-22-003245 · form413392002_12192022.xml · derivative · entry 3

Funicular Funds, LP · CIK 0001937147 · 10% owner · See Footnote 1

Ma-Weaver Jacob · CIK 0001922140 · Director · 10% owner · See Footnote 1

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 30,000

Underlying: Common Stock · 1,420,000 shares

Expires 2022-12-16

F1 · security: This Form 4 is filed by Funicular Funds, LP (the "Fund") and Jacob Ma-Weaver ("Mr. Ma-Weaver" and together with the Fund, the "Reporting Persons"). The Reporting Persons, the Funicular Fund ("Funicular") and Cable Car Capital LLC ("Cable Car") may be deemed to be a member of a Section 13(d) group that may be deemed to collectively beneficially own more than 10% of the Issuer's outstanding shares of Common Stock. The Reporting Persons, Funicular and Cable Car disclaim beneficial ownership of the securities reported herein except to the extent of his or its pecuniary interest therein.

F2 · ownership.direct: Represents securities directly owned by the Fund. Funicular, as a feeder fund to the Fund, may be deemed to beneficially own the securities directly ownedby the Fund. Cable Car, as the general partner of the Fund, may be deemed to beneficially own the securities directly owned by the Fund. Mr. Ma-Weaver, asthe Managing Member of Cable Car, may be deemed to beneficially own the securities directly owned by the Fund.

Read SEC document
December 16, 2022 Filed Dec 19, 2022 22:33 UTC Oruka Therapeutics, Inc. ABIO · Entity 3781 OtherCommon Stock 1,420,000 $2.50 $3,550,000.00
Disclosure

SEC source: 0000921895-22-003245 · form413392002_12192022.xml · nonDerivative · entry 1

Funicular Funds, LP · CIK 0001937147 · 10% owner · See Footnote 1

Ma-Weaver Jacob · CIK 0001922140 · Director · 10% owner · See Footnote 1

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,000,452

F1 · security: This Form 4 is filed by Funicular Funds, LP (the "Fund") and Jacob Ma-Weaver ("Mr. Ma-Weaver" and together with the Fund, the "Reporting Persons"). The Reporting Persons, the Funicular Fund ("Funicular") and Cable Car Capital LLC ("Cable Car") may be deemed to be a member of a Section 13(d) group that may be deemed to collectively beneficially own more than 10% of the Issuer's outstanding shares of Common Stock. The Reporting Persons, Funicular and Cable Car disclaim beneficial ownership of the securities reported herein except to the extent of his or its pecuniary interest therein.

F2 · ownership.direct: Represents securities directly owned by the Fund. Funicular, as a feeder fund to the Fund, may be deemed to beneficially own the securities directly ownedby the Fund. Cable Car, as the general partner of the Fund, may be deemed to beneficially own the securities directly owned by the Fund. Mr. Ma-Weaver, asthe Managing Member of Cable Car, may be deemed to beneficially own the securities directly owned by the Fund.

Read SEC document
December 15, 2022 Filed Dec 19, 2022 22:33 UTC Oruka Therapeutics, Inc. ABIO · Entity 3781 GrantStock Option (right to buy) · Derivative 6,000 $0.00 Strike: $2.32 $0.00
Disclosure

SEC source: 0000921895-22-003245 · form413392002_12192022.xml · derivative · entry 2

Funicular Funds, LP · CIK 0001937147 · 10% owner · See Footnote 1

Ma-Weaver Jacob · CIK 0001922140 · Director · 10% owner · See Footnote 1

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 18,000

Underlying: Common Stock · 6,000 shares

Expires 2032-12-15

F1 · security: This Form 4 is filed by Funicular Funds, LP (the "Fund") and Jacob Ma-Weaver ("Mr. Ma-Weaver" and together with the Fund, the "Reporting Persons"). The Reporting Persons, the Funicular Fund ("Funicular") and Cable Car Capital LLC ("Cable Car") may be deemed to be a member of a Section 13(d) group that may be deemed to collectively beneficially own more than 10% of the Issuer's outstanding shares of Common Stock. The Reporting Persons, Funicular and Cable Car disclaim beneficial ownership of the securities reported herein except to the extent of his or its pecuniary interest therein.

F3 · derivative.exercise_date: Grant to Mr. Ma-Weaver of a stock option under the 2020 Equity Incentive Plan (the "Plan"), vesting in 12 equal monthly installments beginning as of December 15, 2022. If Mr. Ma-Weaver's service as a director of the Issuer terminates in connection with or at any time following a change in control (for whatever reason), then any unexpired options that remain unvested shall become fully vested.

F4 · derivative.underlying_shares: Pursuant to the terms of the Plan, the stock option may not be transferred. Upon vesting, Mr. Ma-Weaver intends on exercising the option and assigning the underlying shares to the Fund.

F2 · ownership.direct: Represents securities directly owned by the Fund. Funicular, as a feeder fund to the Fund, may be deemed to beneficially own the securities directly ownedby the Fund. Cable Car, as the general partner of the Fund, may be deemed to beneficially own the securities directly owned by the Fund. Mr. Ma-Weaver, asthe Managing Member of Cable Car, may be deemed to beneficially own the securities directly owned by the Fund.

Read SEC document
June 15, 2022 Filed Jun 21, 2022 23:42 UTC Oruka Therapeutics, Inc. ABIO · Entity 3781 GrantStock Option (right to buy) · Derivative 12,000 $0.00 Strike: $2.27 $0.00
Disclosure

SEC source: 0000921895-22-002055 · form413392002_06212022.xml · derivative · entry 2

Ma-Weaver Jacob · CIK 0001922140 · Director · 10% owner · See Footnote 1

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,000

Underlying: Common Stock · 12,000 shares

Expires 2032-06-15

F1 · security: This Form 4 is filed by Jacob Ma-Weaver (the "Reporting Person"). The Reporting Person, the Funicular Fund (the "Fund") and Cable Car Capital LLC ("Cable Car") may be deemed to be a member of a Section 13(d) group that may be deemed to collectively beneficially own more than 10% of the Issuer's outstanding shares of Common Stock (the "Shares"). Each of the Reporting Person, the Fund and Cable Car disclaim beneficial ownership of the securities reported herein except to the extent of his or its pecuniary interest therein.

F3 · derivative.exercise_date: Grant to the Reporting Person of a stock option under the 2020 Equity Incentive Plan (the Plan), vesting in 36 equal monthly installments from the date of grant, provided that the Reporting Person's continuous service to the Issuer has not been terminated as defined in or as determined under the Plan prior to such time. In the event of a change in control of the Issuer, 50% of the unvested options shall become fully and immediately vested upon the closing date of such change in control, provided, however, that on the earlier of (i) the one-year anniversary of the closing date or (ii) involuntary termination, any options that remain unvested on such earlier date shall become fully and immediately vested.

F4 · derivative.underlying_shares: Pursuant to the terms of the Plan, the stock option may not be transferred. Upon vesting, the Reporting Person intends on exercising the option and assigning the underlying shares to the Fund.

Read SEC document
May 25, 2022 Filed May 25, 2022 21:12 UTC Oruka Therapeutics, Inc. ABIO · Entity 3781 PurchaseCommon Stock 64,851 $2.32 $150,739.66
Disclosure

SEC source: 0000921895-22-001792 · form413392002_05252022.xml · nonDerivative · entry 3

Funicular Fund, LP · CIK 0001752618 · See Footnote 1

Ma-Weaver Jacob · CIK 0001922140 · See Footnote 1

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,580,452

F1 · security: This Form 4 is filed by the Funicular Fund, LP (the "Fund") and Jacob Ma-Weaver (the "Reporting Persons"). The Reporting Persons and Cable Car Capital LLC ("Cable Car") may be deemed to be a member of a Section 13(d) group that may be deemed to collectively beneficially own more than 10% of the Issuer's outstanding shares of Common Stock (the "Shares"). Each of the Reporting Persons and Cable Car disclaim beneficial ownership of the securities reported herein except to the extent of his or its pecuniary interest therein.

F4 · price: Represents a weighted average price. These Shares were purchased in multiple transactions at prices ranging from $2.2550 to $2.3450, inclusive of brokerage commissions. The Reporting Persons undertake to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of Shares purchased at each separate price within the range set forth in this footnote.

F2 · ownership.direct: Represents securities directly owned by the Fund. Cable Car, as the general partner of the Fund, may be deemed to beneficially own the securities directly owned by the Fund. Mr. Ma-Weaver, as the Managing Member of Cable Car, may be deemed to beneficially own the securities directly owned by the Fund.

Read SEC document
May 24, 2022 Filed May 25, 2022 21:12 UTC Oruka Therapeutics, Inc. ABIO · Entity 3781 PurchaseCommon Stock 18,110 $2.29 $41,383.16
Disclosure

SEC source: 0000921895-22-001792 · form413392002_05252022.xml · nonDerivative · entry 2

Funicular Fund, LP · CIK 0001752618 · See Footnote 1

Ma-Weaver Jacob · CIK 0001922140 · See Footnote 1

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,515,601

F1 · security: This Form 4 is filed by the Funicular Fund, LP (the "Fund") and Jacob Ma-Weaver (the "Reporting Persons"). The Reporting Persons and Cable Car Capital LLC ("Cable Car") may be deemed to be a member of a Section 13(d) group that may be deemed to collectively beneficially own more than 10% of the Issuer's outstanding shares of Common Stock (the "Shares"). Each of the Reporting Persons and Cable Car disclaim beneficial ownership of the securities reported herein except to the extent of his or its pecuniary interest therein.

F3 · price: Represents a weighted average price. These Shares were purchased in multiple transactions at prices ranging from $2.2850 to $2.2950, inclusive of brokerage commissions. The Reporting Persons undertake to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of Shares purchased at each separate price within the range set forth in this footnote.

F2 · ownership.direct: Represents securities directly owned by the Fund. Cable Car, as the general partner of the Fund, may be deemed to beneficially own the securities directly owned by the Fund. Mr. Ma-Weaver, as the Managing Member of Cable Car, may be deemed to beneficially own the securities directly owned by the Fund.

Read SEC document
May 23, 2022 Filed May 25, 2022 21:12 UTC Oruka Therapeutics, Inc. ABIO · Entity 3781 PurchaseCommon Stock 2,301 $2.30 $5,280.80
Disclosure

SEC source: 0000921895-22-001792 · form413392002_05252022.xml · nonDerivative · entry 1

Funicular Fund, LP · CIK 0001752618 · See Footnote 1

Ma-Weaver Jacob · CIK 0001922140 · See Footnote 1

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,497,491

F1 · security: This Form 4 is filed by the Funicular Fund, LP (the "Fund") and Jacob Ma-Weaver (the "Reporting Persons"). The Reporting Persons and Cable Car Capital LLC ("Cable Car") may be deemed to be a member of a Section 13(d) group that may be deemed to collectively beneficially own more than 10% of the Issuer's outstanding shares of Common Stock (the "Shares"). Each of the Reporting Persons and Cable Car disclaim beneficial ownership of the securities reported herein except to the extent of his or its pecuniary interest therein.

F2 · ownership.direct: Represents securities directly owned by the Fund. Cable Car, as the general partner of the Fund, may be deemed to beneficially own the securities directly owned by the Fund. Mr. Ma-Weaver, as the Managing Member of Cable Car, may be deemed to beneficially own the securities directly owned by the Fund.

Read SEC document
May 19, 2022 Filed May 20, 2022 22:01 UTC Oruka Therapeutics, Inc. ABIO · Entity 3781 PurchaseCommon Stock 1 $2.25 $2.25
Disclosure

SEC source: 0000921895-22-001755 · form413392002_05202022.xml · nonDerivative · entry 2

Funicular Fund, LP · CIK 0001752618 · See Footnote 1

Ma-Weaver Jacob · CIK 0001922140 · See Footnote 1

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,495,190

F1 · security: This Form 4 is filed by the Funicular Fund, LP (the "Fund") and Jacob Ma-Weaver (the "Reporting Persons"). The Reporting Persons and Cable Car Capital LLC ("Cable Car") may be deemed to be a member of a Section 13(d) group that may be deemed to collectively beneficially own more than 10% of the Issuer's outstanding shares of Common Stock (the "Shares"). Each of the Reporting Persons and Cable Car disclaim beneficial ownership of the securities reported herein except to the extent of his or its pecuniary interest therein.

F3 · ownership.direct: Represents securities directly owned by the Fund. Cable Car, as the general partner of the Fund, may be deemed to beneficially own the securities directly owned by the Fund. Mr. Ma-Weaver, as the Managing Member of Cable Car, may be deemed to beneficially own the securities directly owned by the Fund.

Read SEC document
May 18, 2022 Filed May 20, 2022 22:01 UTC Oruka Therapeutics, Inc. ABIO · Entity 3781 PurchaseCommon Stock 13,072 $2.30 $30,125.73
Disclosure

SEC source: 0000921895-22-001755 · form413392002_05202022.xml · nonDerivative · entry 1

Funicular Fund, LP · CIK 0001752618 · See Footnote 1

Ma-Weaver Jacob · CIK 0001922140 · See Footnote 1

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,495,189

F1 · security: This Form 4 is filed by the Funicular Fund, LP (the "Fund") and Jacob Ma-Weaver (the "Reporting Persons"). The Reporting Persons and Cable Car Capital LLC ("Cable Car") may be deemed to be a member of a Section 13(d) group that may be deemed to collectively beneficially own more than 10% of the Issuer's outstanding shares of Common Stock (the "Shares"). Each of the Reporting Persons and Cable Car disclaim beneficial ownership of the securities reported herein except to the extent of his or its pecuniary interest therein.

F2 · price: Represents a weighted average price. These Shares were purchased in multiple transactions at prices ranging from $2.2850 to $2.3050, inclusive of brokerage commissions. The Reporting Persons undertake to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of Shares purchased at each separate price within the range set forth in this footnote.

F3 · ownership.direct: Represents securities directly owned by the Fund. Cable Car, as the general partner of the Fund, may be deemed to beneficially own the securities directly owned by the Fund. Mr. Ma-Weaver, as the Managing Member of Cable Car, may be deemed to beneficially own the securities directly owned by the Fund.

Read SEC document
May 16, 2022 Filed May 16, 2022 23:31 UTC Oruka Therapeutics, Inc. ABIO · Entity 3781 PurchaseCommon Stock 42,914 $2.30 $98,646.41
Disclosure

SEC source: 0000921895-22-001688 · form413392002_05162022.xml · nonDerivative · entry 3

Funicular Fund, LP · CIK 0001752618 · See Footnote 1

Ma-Weaver Jacob · CIK 0001922140 · See Footnote 1

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,482,117

F1 · security: This Form 4 is filed by the Funicular Fund, LP (the "Fund") and Jacob Ma-Weaver (the "Reporting Persons"). The Reporting Persons and Cable Car Capital LLC ("Cable Car") may be deemed to be a member of a Section 13(d) group that may be deemed to collectively beneficially own more than 10% of the Issuer's outstanding shares of Common Stock (the "Shares"). Each of the Reporting Persons and Cable Car disclaim beneficial ownership of the securities reported herein except to the extent of his or its pecuniary interest therein.

F5 · price: Represents a weighted average price. These Shares were purchased in multiple transactions at prices ranging from $2.2400 to $2.3050, inclusive of brokerage commissions. The Reporting Persons undertake to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of Shares purchased at each separate price within the range set forth in this footnote.

F3 · ownership.direct: Represents securities directly owned by the Fund. Cable Car, as the general partner of the Fund, may be deemed to beneficially own the securities directly owned by the Fund. Mr. Ma-Weaver, as the Managing Member of Cable Car, may be deemed to beneficially own the securities directly owned by the Fund.

Read SEC document
May 13, 2022 Filed May 16, 2022 23:31 UTC Oruka Therapeutics, Inc. ABIO · Entity 3781 PurchaseCommon Stock 14,000 $2.29 $32,118.80
Disclosure

SEC source: 0000921895-22-001688 · form413392002_05162022.xml · nonDerivative · entry 2

Funicular Fund, LP · CIK 0001752618 · See Footnote 1

Ma-Weaver Jacob · CIK 0001922140 · See Footnote 1

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,439,203

F1 · security: This Form 4 is filed by the Funicular Fund, LP (the "Fund") and Jacob Ma-Weaver (the "Reporting Persons"). The Reporting Persons and Cable Car Capital LLC ("Cable Car") may be deemed to be a member of a Section 13(d) group that may be deemed to collectively beneficially own more than 10% of the Issuer's outstanding shares of Common Stock (the "Shares"). Each of the Reporting Persons and Cable Car disclaim beneficial ownership of the securities reported herein except to the extent of his or its pecuniary interest therein.

F4 · price: Represents a weighted average price. These Shares were purchased in multiple transactions at prices ranging from $2.2550 to $2.3050, inclusive of brokerage commissions. The Reporting Persons undertake to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of Shares purchased at each separate price within the range set forth in this footnote.

F3 · ownership.direct: Represents securities directly owned by the Fund. Cable Car, as the general partner of the Fund, may be deemed to beneficially own the securities directly owned by the Fund. Mr. Ma-Weaver, as the Managing Member of Cable Car, may be deemed to beneficially own the securities directly owned by the Fund.

Read SEC document
May 12, 2022 Filed May 16, 2022 23:31 UTC Oruka Therapeutics, Inc. ABIO · Entity 3781 PurchaseCommon Stock 27,922 $2.27 $63,377.36
Disclosure

SEC source: 0000921895-22-001688 · form413392002_05162022.xml · nonDerivative · entry 1

Funicular Fund, LP · CIK 0001752618 · See Footnote 1

Ma-Weaver Jacob · CIK 0001922140 · See Footnote 1

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,425,203

F1 · security: This Form 4 is filed by the Funicular Fund, LP (the "Fund") and Jacob Ma-Weaver (the "Reporting Persons"). The Reporting Persons and Cable Car Capital LLC ("Cable Car") may be deemed to be a member of a Section 13(d) group that may be deemed to collectively beneficially own more than 10% of the Issuer's outstanding shares of Common Stock (the "Shares"). Each of the Reporting Persons and Cable Car disclaim beneficial ownership of the securities reported herein except to the extent of his or its pecuniary interest therein.

F2 · price: Represents a weighted average price. These Shares were purchased in multiple transactions at prices ranging from $2.2650 to $2.2950, inclusive of brokerage commissions. The Reporting Persons undertake to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of Shares purchased at each separate price within the range set forth in this footnote.

F3 · ownership.direct: Represents securities directly owned by the Fund. Cable Car, as the general partner of the Fund, may be deemed to beneficially own the securities directly owned by the Fund. Mr. Ma-Weaver, as the Managing Member of Cable Car, may be deemed to beneficially own the securities directly owned by the Fund.

Read SEC document
May 11, 2022 Filed May 11, 2022 22:38 UTC Oruka Therapeutics, Inc. ABIO · Entity 3781 PurchaseCommon Stock 24,596 $2.29 $56,201.86
Disclosure

SEC source: 0000921895-22-001599 · form413392002_05112022.xml · nonDerivative · entry 2

Funicular Fund, LP · CIK 0001752618 · See Footnote 1

Ma-Weaver Jacob · CIK 0001922140 · See Footnote 1

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,397,281

F1 · security: This Form 4 is filed by the Funicular Fund, LP (the "Fund") and Jacob Ma-Weaver (the "Reporting Persons"). The Reporting Persons and Cable Car Capital LLC ("Cable Car") may be deemed to be a member of a Section 13(d) group that may be deemed to collectively beneficially own more than 10% of the Issuer's outstanding shares of Common Stock (the "Shares"). Each of the Reporting Persons and Cable Car disclaim beneficial ownership of the securities reported herein except to the extent of his or its pecuniary interest therein.

F3 · ownership.direct: Represents securities directly owned by the Fund. Cable Car, as the general partner of the Fund, may be deemed to beneficially own the securities directly owned by the Fund. Mr. Ma-Weaver, as the Managing Member of Cable Car, may be deemed to beneficially own the securities directly owned by the Fund.

Read SEC document
May 10, 2022 Filed May 11, 2022 22:38 UTC Oruka Therapeutics, Inc. ABIO · Entity 3781 PurchaseCommon Stock 20,979 $2.28 $47,926.53
Disclosure

SEC source: 0000921895-22-001599 · form413392002_05112022.xml · nonDerivative · entry 1

Funicular Fund, LP · CIK 0001752618 · See Footnote 1

Ma-Weaver Jacob · CIK 0001922140 · See Footnote 1

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,372,685

F1 · security: This Form 4 is filed by the Funicular Fund, LP (the "Fund") and Jacob Ma-Weaver (the "Reporting Persons"). The Reporting Persons and Cable Car Capital LLC ("Cable Car") may be deemed to be a member of a Section 13(d) group that may be deemed to collectively beneficially own more than 10% of the Issuer's outstanding shares of Common Stock (the "Shares"). Each of the Reporting Persons and Cable Car disclaim beneficial ownership of the securities reported herein except to the extent of his or its pecuniary interest therein.

F2 · price: Represents a weighted average price. These Shares were purchased in multiple transactions at prices ranging from $2.2750 to $2.2850, inclusive of brokerage commissions. The Reporting Persons undertake to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of Shares purchased at each separate price within the range set forth in this footnote.

F3 · ownership.direct: Represents securities directly owned by the Fund. Cable Car, as the general partner of the Fund, may be deemed to beneficially own the securities directly owned by the Fund. Mr. Ma-Weaver, as the Managing Member of Cable Car, may be deemed to beneficially own the securities directly owned by the Fund.

Read SEC document
May 09, 2022 Filed May 9, 2022 21:44 UTC Oruka Therapeutics, Inc. ABIO · Entity 3781 PurchaseCommon Stock 49,221 $2.27 $111,721.83
Disclosure

SEC source: 0000921895-22-001519 · form413392002_05092022.xml · nonDerivative · entry 3

Funicular Fund, LP · CIK 0001752618 · See Footnote 1

Ma-Weaver Jacob · CIK 0001922140 · See Footnote 1

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,351,706

F1 · security: This Form 4 is filed by the Funicular Fund, LP (the "Fund") and Jacob Ma-Weaver (the "Reporting Persons"). The Reporting Persons and Cable Car Capital LLC ("Cable Car") may be deemed to be a member of a Section 13(d) group that may be deemed to collectively beneficially own more than 10% of the Issuer's outstanding shares of Common Stock (the "Shares"). Each of the Reporting Persons and Cable Car disclaim beneficial ownership of the securities reported herein except to the extent of his or its pecuniary interest therein.

F5 · price: Represents a weighted average price. These Shares were purchased in multiple transactions at prices ranging from $2.2650 to $2.2750, inclusive of brokerage commissions. The Reporting Persons undertake to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of Shares purchased at each separate price within the range set forth in this footnote.

F3 · ownership.direct: Represents securities directly owned by the Fund. Cable Car, as the general partner of the Fund, may be deemed to beneficially own the securities directly owned by the Fund. Mr. Ma-Weaver, as the Managing Member of Cable Car, may be deemed to beneficially own the securities directly owned by the Fund.

Read SEC document
May 06, 2022 Filed May 9, 2022 21:44 UTC Oruka Therapeutics, Inc. ABIO · Entity 3781 PurchaseCommon Stock 57,998 $2.28 $132,392.03
Disclosure

SEC source: 0000921895-22-001519 · form413392002_05092022.xml · nonDerivative · entry 2

Funicular Fund, LP · CIK 0001752618 · See Footnote 1

Ma-Weaver Jacob · CIK 0001922140 · See Footnote 1

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,302,485

F1 · security: This Form 4 is filed by the Funicular Fund, LP (the "Fund") and Jacob Ma-Weaver (the "Reporting Persons"). The Reporting Persons and Cable Car Capital LLC ("Cable Car") may be deemed to be a member of a Section 13(d) group that may be deemed to collectively beneficially own more than 10% of the Issuer's outstanding shares of Common Stock (the "Shares"). Each of the Reporting Persons and Cable Car disclaim beneficial ownership of the securities reported herein except to the extent of his or its pecuniary interest therein.

F4 · price: Represents a weighted average price. These Shares were purchased in multiple transactions at prices ranging from $2.2600 to $2.2850, inclusive of brokerage commissions. The Reporting Persons undertake to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of Shares purchased at each separate price within the range set forth in this footnote.

F3 · ownership.direct: Represents securities directly owned by the Fund. Cable Car, as the general partner of the Fund, may be deemed to beneficially own the securities directly owned by the Fund. Mr. Ma-Weaver, as the Managing Member of Cable Car, may be deemed to beneficially own the securities directly owned by the Fund.

Read SEC document
May 05, 2022 Filed May 9, 2022 21:44 UTC Oruka Therapeutics, Inc. ABIO · Entity 3781 PurchaseCommon Stock 16,903 $2.27 $38,449.25
Disclosure

SEC source: 0000921895-22-001519 · form413392002_05092022.xml · nonDerivative · entry 1

Funicular Fund, LP · CIK 0001752618 · See Footnote 1

Ma-Weaver Jacob · CIK 0001922140 · See Footnote 1

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,244,487

F1 · security: This Form 4 is filed by the Funicular Fund, LP (the "Fund") and Jacob Ma-Weaver (the "Reporting Persons"). The Reporting Persons and Cable Car Capital LLC ("Cable Car") may be deemed to be a member of a Section 13(d) group that may be deemed to collectively beneficially own more than 10% of the Issuer's outstanding shares of Common Stock (the "Shares"). Each of the Reporting Persons and Cable Car disclaim beneficial ownership of the securities reported herein except to the extent of his or its pecuniary interest therein.

F2 · price: Represents a weighted average price. These Shares were purchased in multiple transactions at prices ranging from $2.2650 to $2.2750, inclusive of brokerage commissions. The Reporting Persons undertake to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of Shares purchased at each separate price within the range set forth in this footnote.

F3 · ownership.direct: Represents securities directly owned by the Fund. Cable Car, as the general partner of the Fund, may be deemed to beneficially own the securities directly owned by the Fund. Mr. Ma-Weaver, as the Managing Member of Cable Car, may be deemed to beneficially own the securities directly owned by the Fund.

Read SEC document
May 02, 2022 Filed May 2, 2022 23:03 UTC Oruka Therapeutics, Inc. ABIO · Entity 3781 PurchaseCommon Stock 1,259 $2.32 $2,914.59
Disclosure

SEC source: 0000921895-22-001438 · form413392002_05022022.xml · nonDerivative · entry 3

Funicular Fund, LP · CIK 0001752618 · See Footnote 1

Ma-Weaver Jacob · CIK 0001922140 · See Footnote 1

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,227,584

F1 · security: This Form 4 is filed by the Funicular Fund, LP (the "Fund") and Jacob Ma-Weaver (the "Reporting Persons"). The Reporting Persons and Cable Car Capital LLC ("Cable Car") may be deemed to be a member of a Section 13(d) group that may be deemed to collectively beneficially own more than 10% of the Issuer's outstanding shares of Common Stock (the "Shares"). Each of the Reporting Persons and Cable Car disclaim beneficial ownership of the securities reported herein except to the extent of his or its pecuniary interest therein.

F3 · ownership.direct: Represents securities directly owned by the Fund. Cable Car, as the general partner of the Fund, may be deemed to beneficially own the securities directly owned by the Fund. Mr. Ma-Weaver, as the Managing Member of Cable Car, may be deemed to beneficially own the securities directly owned by the Fund.

Read SEC document
April 29, 2022 Filed May 2, 2022 23:03 UTC Oruka Therapeutics, Inc. ABIO · Entity 3781 PurchaseCommon Stock 8,974 $2.30 $20,643.79
Disclosure

SEC source: 0000921895-22-001438 · form413392002_05022022.xml · nonDerivative · entry 2

Funicular Fund, LP · CIK 0001752618 · See Footnote 1

Ma-Weaver Jacob · CIK 0001922140 · See Footnote 1

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,226,325

F1 · security: This Form 4 is filed by the Funicular Fund, LP (the "Fund") and Jacob Ma-Weaver (the "Reporting Persons"). The Reporting Persons and Cable Car Capital LLC ("Cable Car") may be deemed to be a member of a Section 13(d) group that may be deemed to collectively beneficially own more than 10% of the Issuer's outstanding shares of Common Stock (the "Shares"). Each of the Reporting Persons and Cable Car disclaim beneficial ownership of the securities reported herein except to the extent of his or its pecuniary interest therein.

F4 · price: Represents a weighted average price. These Shares were purchased in multiple transactions at prices ranging from $2.2750 to $2.3150, inclusive of brokerage commissions. The Reporting Persons undertake to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of Shares purchased at each separate price within the range set forth in this footnote.

F3 · ownership.direct: Represents securities directly owned by the Fund. Cable Car, as the general partner of the Fund, may be deemed to beneficially own the securities directly owned by the Fund. Mr. Ma-Weaver, as the Managing Member of Cable Car, may be deemed to beneficially own the securities directly owned by the Fund.

Read SEC document
April 28, 2022 Filed May 2, 2022 23:03 UTC Oruka Therapeutics, Inc. ABIO · Entity 3781 PurchaseCommon Stock 23,381 $2.32 $54,171.44
Disclosure

SEC source: 0000921895-22-001438 · form413392002_05022022.xml · nonDerivative · entry 1

Funicular Fund, LP · CIK 0001752618 · See Footnote 1

Ma-Weaver Jacob · CIK 0001922140 · See Footnote 1

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,217,351

F1 · security: This Form 4 is filed by the Funicular Fund, LP (the "Fund") and Jacob Ma-Weaver (the "Reporting Persons"). The Reporting Persons and Cable Car Capital LLC ("Cable Car") may be deemed to be a member of a Section 13(d) group that may be deemed to collectively beneficially own more than 10% of the Issuer's outstanding shares of Common Stock (the "Shares"). Each of the Reporting Persons and Cable Car disclaim beneficial ownership of the securities reported herein except to the extent of his or its pecuniary interest therein.

F2 · price: Represents a weighted average price. These Shares were purchased in multiple transactions at prices ranging from $2.2650 to $2.3250, inclusive of brokerage commissions. The Reporting Persons undertake to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of Shares purchased at each separate price within the range set forth in this footnote.

F3 · ownership.direct: Represents securities directly owned by the Fund. Cable Car, as the general partner of the Fund, may be deemed to beneficially own the securities directly owned by the Fund. Mr. Ma-Weaver, as the Managing Member of Cable Car, may be deemed to beneficially own the securities directly owned by the Fund.

Read SEC document
April 25, 2022 Filed Apr 27, 2022 22:33 UTC Oruka Therapeutics, Inc. ABIO · Entity 3781 SalePut Option (obligation to buy) · Derivative 7,500 $64.00 Strike: $2.50 $480,000.00
Disclosure

SEC source: 0000921895-22-001390 · form413392002_04272022.xml · derivative · entry 2

Funicular Fund, LP · CIK 0001752618 · See Footnote 1

Ma-Weaver Jacob · CIK 0001922140 · See Footnote 1

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 14,500

Underlying: Common Stock · 1,450,000 shares

Expires 2022-12-16

F1 · security: This Form 4 is filed by the Funicular Fund, LP (the "Fund") and Jacob Ma-Weaver (the "Reporting Persons"). The Reporting Persons and Cable Car Capital LLC ("Cable Car") may be deemed to be a member of a Section 13(d) group that may be deemed to collectively beneficially own more than 10% of the Issuer's outstanding shares of Common Stock (the "Shares"). Each of the Reporting Persons and Cable Car disclaim beneficial ownership of the securities reported herein except to the extent of his or its pecuniary interest therein.

F4 · security: The Fund wrote 7,500 European-Style put option contracts expiring in December 2022 (the "Put Options") which provide that the Fund will be required to purchase shares of Common Stock at the stated strike price if the counterparty exercises such option. The price of the premium received by the Fund for each contract includes brokerage commissions.

F4 · price: The Fund wrote 7,500 European-Style put option contracts expiring in December 2022 (the "Put Options") which provide that the Fund will be required to purchase shares of Common Stock at the stated strike price if the counterparty exercises such option. The price of the premium received by the Fund for each contract includes brokerage commissions.

F4 · ownership.direct: The Fund wrote 7,500 European-Style put option contracts expiring in December 2022 (the "Put Options") which provide that the Fund will be required to purchase shares of Common Stock at the stated strike price if the counterparty exercises such option. The price of the premium received by the Fund for each contract includes brokerage commissions.

Read SEC document
April 25, 2022 Filed Apr 27, 2022 22:33 UTC Oruka Therapeutics, Inc. ABIO · Entity 3781 PurchaseCommon Stock 13,751 $2.29 $31,507.67
Disclosure

SEC source: 0000921895-22-001390 · form413392002_04272022.xml · nonDerivative · entry 1

Funicular Fund, LP · CIK 0001752618 · See Footnote 1

Ma-Weaver Jacob · CIK 0001922140 · See Footnote 1

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,193,970

F1 · security: This Form 4 is filed by the Funicular Fund, LP (the "Fund") and Jacob Ma-Weaver (the "Reporting Persons"). The Reporting Persons and Cable Car Capital LLC ("Cable Car") may be deemed to be a member of a Section 13(d) group that may be deemed to collectively beneficially own more than 10% of the Issuer's outstanding shares of Common Stock (the "Shares"). Each of the Reporting Persons and Cable Car disclaim beneficial ownership of the securities reported herein except to the extent of his or its pecuniary interest therein.

F2 · price: Represents a weighted average price. These Shares were purchased in multiple transactions at prices ranging from $2.2750 to $2.3050, inclusive of brokerage commissions. The Reporting Persons undertake to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of Shares purchased at each separate price within the range set forth in this footnote.

F3 · ownership.direct: Represents securities directly owned by the Fund. Cable Car, as the general partner of the Fund, may be deemed to beneficially own the securities directly owned by the Fund. Mr. Ma-Weaver, as the Managing Member of Cable Car, may be deemed to beneficially own the securities directly owned by the Fund.

Read SEC document
April 19, 2022 Filed Apr 20, 2022 23:43 UTC Oruka Therapeutics, Inc. ABIO · Entity 3781 SalePut Option (obligation to buy) · Derivative 7,000 $64.00 Strike: $2.50 $448,000.00
Disclosure

SEC source: 0000921895-22-001318 · form413392002_04202022.xml · derivative · entry 2

Funicular Fund, LP · CIK 0001752618 · See Footnote 1

Ma-Weaver Jacob · CIK 0001922140 · See Footnote 1

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,000

Underlying: Common Stock · 700,000 shares

Expires 2022-12-16

F1 · security: This Form 4 is filed by the Funicular Fund, LP (the "Fund") and Jacob Ma-Weaver (the "Reporting Persons"). The Reporting Persons and Cable Car Capital LLC ("Cable Car") may be deemed to be a member of a Section 13(d) group that may be deemed to collectively beneficially own more than 10% of the Issuer's outstanding shares of Common Stock (the "Shares"). Each of the Reporting Persons and Cable Car disclaim beneficial ownership of the securities reported herein except to the extent of his or its pecuniary interest therein.

F4 · security: The Fund wrote 7,000 European-Style put option contracts expiring in December 2022 (the "Put Options") which provide that the Fund will be required to purchase shares of Common Stock at the stated strike price if the counterparty exercises such option. The price of the premium received by the Fund for each contract includes brokerage commissions.

F4 · price: The Fund wrote 7,000 European-Style put option contracts expiring in December 2022 (the "Put Options") which provide that the Fund will be required to purchase shares of Common Stock at the stated strike price if the counterparty exercises such option. The price of the premium received by the Fund for each contract includes brokerage commissions.

F4 · ownership.direct: The Fund wrote 7,000 European-Style put option contracts expiring in December 2022 (the "Put Options") which provide that the Fund will be required to purchase shares of Common Stock at the stated strike price if the counterparty exercises such option. The price of the premium received by the Fund for each contract includes brokerage commissions.

Read SEC document
April 18, 2022 Filed Apr 20, 2022 23:43 UTC Oruka Therapeutics, Inc. ABIO · Entity 3781 PurchaseCommon Stock 9,119 $2.31 $21,080.39
Disclosure

SEC source: 0000921895-22-001318 · form413392002_04202022.xml · nonDerivative · entry 1

Funicular Fund, LP · CIK 0001752618 · See Footnote 1

Ma-Weaver Jacob · CIK 0001922140 · See Footnote 1

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,180,219

F1 · security: This Form 4 is filed by the Funicular Fund, LP (the "Fund") and Jacob Ma-Weaver (the "Reporting Persons"). The Reporting Persons and Cable Car Capital LLC ("Cable Car") may be deemed to be a member of a Section 13(d) group that may be deemed to collectively beneficially own more than 10% of the Issuer's outstanding shares of Common Stock (the "Shares"). Each of the Reporting Persons and Cable Car disclaim beneficial ownership of the securities reported herein except to the extent of his or its pecuniary interest therein.

F2 · price: Represents a weighted average price. These Shares were purchased in multiple transactions at prices ranging from $2.3050 to $2.3150, inclusive of brokerage commissions. The Reporting Persons undertake to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of Shares purchased at each separate price within the range set forth in this footnote.

F3 · ownership.direct: Represents securities directly owned by the Fund. Cable Car, as the general partner of the Fund, may be deemed to beneficially own the securities directly owned by the Fund. Mr. Ma-Weaver, as the Managing Member of Cable Car, may be deemed to beneficially own the securities directly owned by the Fund.

Read SEC document
April 14, 2022 Filed Apr 15, 2022 00:04 UTC Oruka Therapeutics, Inc. ABIO · Entity 3781 PurchaseCommon Stock 17,410 $2.33 $40,546.15
Disclosure

SEC source: 0000921895-22-001257 · form413392002_04142022.xml · nonDerivative · entry 1

Funicular Fund, LP · CIK 0001752618 · See Footnote 1

Ma-Weaver Jacob · CIK 0001922140 · See Footnote 1

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,171,100

F1 · security: This Form 4 is filed by the Funicular Fund, LP (the "Fund") and Jacob Ma-Weaver (the "Reporting Persons"). The Reporting Persons and Cable Car Capital LLC ("Cable Car") may be deemed to be a member of a Section 13(d) group that may be deemed to collectively beneficially own more than 10% of the Issuer's outstanding shares of Common Stock. Each of the Reporting Persons and Cable Car disclaim beneficial ownership of the securities reported herein except to the extent of his or its pecuniary interest therein.

F2 · price: Represents a weighted average price. These Shares were purchased in multiple transactions at prices ranging from $2.3050 to $2.3350, inclusive of brokerage commissions. The Reporting Persons undertake to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of Shares purchased at each separate price within the range set forth in this footnote.

F3 · ownership.direct: Represents securities directly owned by the Fund. Cable Car, as the general partner of the Fund, may be deemed to beneficially own the securities directly owned by the Fund. Mr. Ma-Weaver, as the Managing Member of Cable Car, may be deemed to beneficially own the securities directly owned by the Fund.

Read SEC document
April 12, 2022 Filed Apr 12, 2022 23:31 UTC Oruka Therapeutics, Inc. ABIO · Entity 3781 PurchaseCommon Stock 69,398 $2.32 $161,100.52
Disclosure

SEC source: 0000921895-22-001225 · form413392002_04122022.xml · nonDerivative · entry 3

Funicular Fund, LP · CIK 0001752618 · See Footnote 1

Ma-Weaver Jacob · CIK 0001922140 · See Footnote 1

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,153,690

F1 · security: This Form 4 is filed by the Funicular Fund, LP (the "Fund") and Jacob Ma-Weaver (the "Reporting Persons"). The Reporting Persons and Cable Car Capital LLC ("Cable Car") may be deemed to be a member of a Section 13(d) group that may be deemed to collectively beneficially own more than 10% of the Issuer's outstanding shares of Common Stock. Each of the Reporting Persons and Cable Car disclaim beneficial ownership of the securities reported herein except to the extent of his or its pecuniary interest therein.

F3 · price: Represents a weighted average price. These Shares were purchased in multiple transactions at prices ranging from $2.3050 to $2.3250, inclusive of brokerage commissions. The Reporting Persons undertake to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of Shares purchased at each separate price within the range set forth in this footnote.

F4 · ownership.direct: Represents securities directly owned by the Fund. Cable Car, as the general partner of the Fund, may be deemed to beneficially own the securities directly owned by the Fund. Mr. Ma-Weaver, as the Managing Member of Cable Car, may be deemed to beneficially own the securities directly owned by the Fund.

Read SEC document
April 11, 2022 Filed Apr 12, 2022 23:31 UTC Oruka Therapeutics, Inc. ABIO · Entity 3781 PurchaseCommon Stock 4,655 $2.32 $10,776.33
Disclosure

SEC source: 0000921895-22-001225 · form413392002_04122022.xml · nonDerivative · entry 2

Funicular Fund, LP · CIK 0001752618 · See Footnote 1

Ma-Weaver Jacob · CIK 0001922140 · See Footnote 1

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,084,292

F1 · security: This Form 4 is filed by the Funicular Fund, LP (the "Fund") and Jacob Ma-Weaver (the "Reporting Persons"). The Reporting Persons and Cable Car Capital LLC ("Cable Car") may be deemed to be a member of a Section 13(d) group that may be deemed to collectively beneficially own more than 10% of the Issuer's outstanding shares of Common Stock. Each of the Reporting Persons and Cable Car disclaim beneficial ownership of the securities reported herein except to the extent of his or its pecuniary interest therein.

F4 · ownership.direct: Represents securities directly owned by the Fund. Cable Car, as the general partner of the Fund, may be deemed to beneficially own the securities directly owned by the Fund. Mr. Ma-Weaver, as the Managing Member of Cable Car, may be deemed to beneficially own the securities directly owned by the Fund.

Read SEC document
April 08, 2022 Filed Apr 12, 2022 23:31 UTC Oruka Therapeutics, Inc. ABIO · Entity 3781 PurchaseCommon Stock 30,660 $2.31 $70,852.19
Disclosure

SEC source: 0000921895-22-001225 · form413392002_04122022.xml · nonDerivative · entry 1

Funicular Fund, LP · CIK 0001752618 · See Footnote 1

Ma-Weaver Jacob · CIK 0001922140 · See Footnote 1

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,079,637

F1 · security: This Form 4 is filed by the Funicular Fund, LP (the "Fund") and Jacob Ma-Weaver (the "Reporting Persons"). The Reporting Persons and Cable Car Capital LLC ("Cable Car") may be deemed to be a member of a Section 13(d) group that may be deemed to collectively beneficially own more than 10% of the Issuer's outstanding shares of Common Stock. Each of the Reporting Persons and Cable Car disclaim beneficial ownership of the securities reported herein except to the extent of his or its pecuniary interest therein.

F2 · price: Represents a weighted average price. These Shares were purchased in multiple transactions at prices ranging from $2.3050 to $2.3350, inclusive of brokerage commissions. The Reporting Persons undertake to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of Shares purchased at each separate price within the range set forth in this footnote.

F4 · ownership.direct: Represents securities directly owned by the Fund. Cable Car, as the general partner of the Fund, may be deemed to beneficially own the securities directly owned by the Fund. Mr. Ma-Weaver, as the Managing Member of Cable Car, may be deemed to beneficially own the securities directly owned by the Fund.

Read SEC document
April 07, 2022 Filed Apr 8, 2022 00:38 UTC Oruka Therapeutics, Inc. ABIO · Entity 3781 PurchaseCommon Stock 27,450 $2.32 $63,705.96
Disclosure

SEC source: 0000921895-22-001178 · form413392002_04072022.xml · nonDerivative · entry 3

Funicular Fund, LP · CIK 0001752618 · See Footnote 1

Ma-Weaver Jacob · CIK 0001922140 · See Footnote 1

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,048,977

F1 · security: This Form 4 is filed by the Funicular Fund, LP (the "Fund") and Jacob Ma-Weaver (the "Reporting Persons"). The Reporting Persons and Cable Car Capital LLC ("Cable Car") may be deemed to be a member of a Section 13(d) group that may be deemed to collectively beneficially own more than 10% of the Issuer's outstanding shares of Common Stock. Each of the Reporting Persons and Cable Car disclaim beneficial ownership of the securities reported herein except to the extent of his or its pecuniary interest therein.

F4 · price: Represents a weighted average price. These Shares were purchased in multiple transactions at prices ranging from $2.2950 to $2.3350, inclusive of brokerage commissions. The Reporting Persons undertake to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of Shares purchased at each separate price within the range set forth in this footnote.

F5 · ownership.direct: Represents securities directly owned by the Fund. Cable Car, as the general partner of the Fund, may be deemed to beneficially own the securities directly owned by the Fund. Mr. Ma-Weaver, as the Managing Member of Cable Car, may be deemed to beneficially own the securities directly owned by the Fund.

Read SEC document
April 06, 2022 Filed Apr 8, 2022 00:38 UTC Oruka Therapeutics, Inc. ABIO · Entity 3781 PurchaseCommon Stock 26,806 $2.30 $61,602.87
Disclosure

SEC source: 0000921895-22-001178 · form413392002_04072022.xml · nonDerivative · entry 2

Funicular Fund, LP · CIK 0001752618 · See Footnote 1

Ma-Weaver Jacob · CIK 0001922140 · See Footnote 1

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,021,527

F1 · security: This Form 4 is filed by the Funicular Fund, LP (the "Fund") and Jacob Ma-Weaver (the "Reporting Persons"). The Reporting Persons and Cable Car Capital LLC ("Cable Car") may be deemed to be a member of a Section 13(d) group that may be deemed to collectively beneficially own more than 10% of the Issuer's outstanding shares of Common Stock. Each of the Reporting Persons and Cable Car disclaim beneficial ownership of the securities reported herein except to the extent of his or its pecuniary interest therein.

F3 · price: Represents a weighted average price. These Shares were purchased in multiple transactions at prices ranging from $2.2550 to $2.3050, inclusive of brokerage commissions. The Reporting Persons undertake to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of Shares purchased at each separate price within the range set forth in this footnote.

F5 · ownership.direct: Represents securities directly owned by the Fund. Cable Car, as the general partner of the Fund, may be deemed to beneficially own the securities directly owned by the Fund. Mr. Ma-Weaver, as the Managing Member of Cable Car, may be deemed to beneficially own the securities directly owned by the Fund.

Read SEC document
April 05, 2022 Filed Apr 8, 2022 00:38 UTC Oruka Therapeutics, Inc. ABIO · Entity 3781 PurchaseCommon Stock 49,728 $2.30 $114,468.88
Disclosure

SEC source: 0000921895-22-001178 · form413392002_04072022.xml · nonDerivative · entry 1

Funicular Fund, LP · CIK 0001752618 · See Footnote 1

Ma-Weaver Jacob · CIK 0001922140 · See Footnote 1

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,994,721

F1 · security: This Form 4 is filed by the Funicular Fund, LP (the "Fund") and Jacob Ma-Weaver (the "Reporting Persons"). The Reporting Persons and Cable Car Capital LLC ("Cable Car") may be deemed to be a member of a Section 13(d) group that may be deemed to collectively beneficially own more than 10% of the Issuer's outstanding shares of Common Stock. Each of the Reporting Persons and Cable Car disclaim beneficial ownership of the securities reported herein except to the extent of his or its pecuniary interest therein.

F2 · price: Represents a weighted average price. These Shares were purchased in multiple transactions at prices ranging from $2.2950 to $2.3050, inclusive of brokerage commissions. The Reporting Persons undertake to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of Shares purchased at each separate price within the range set forth in this footnote.

F5 · ownership.direct: Represents securities directly owned by the Fund. Cable Car, as the general partner of the Fund, may be deemed to beneficially own the securities directly owned by the Fund. Mr. Ma-Weaver, as the Managing Member of Cable Car, may be deemed to beneficially own the securities directly owned by the Fund.

Read SEC document
April 04, 2022 Filed Apr 8, 2022 00:36 UTC Amendment Oruka Therapeutics, Inc. ABIO · Entity 3781 PurchaseCommon Stock 122,342 $2.26 $276,309.41
Disclosure

SEC source: 0000921895-22-001177 · form4a13392002_04072022.xml · nonDerivative · entry 1

Funicular Fund, LP · CIK 0001752618 · See Footnote 1

Ma-Weaver Jacob · CIK 0001922140 · See Remarks

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,944,993

F1 · security: This Form 4 is filed by the Funicular Fund LP (the "Fund") and Jacob Ma-Weaver (the "Reporting Persons"). The Reporting Persons and Cable Car Capital LLC ("Cable Car") may be deemed to be a member of a Section 13(d) group that may be deemed to collectively beneficially own more than 10% of the Issuer's outstanding shares of Common Stock. Each of the Reporting Persons and Cable Car disclaim beneficial ownership of the securities reported herein except to the extent of his or its pecuniary interest therein.

F2 · price: Represents a weighted average price. These Shares were purchased in multiple transactions at prices ranging from $2.1650 to $2.3050, inclusive of brokerage commissions. The Reporting Persons undertake to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of Shares purchased at each separate price within the range set forth in this footnote.

F3 · ownership.direct: Represents securities directly owned by the Fund. Cable Car, as the general partner of the Fund, may be deemed to beneficially own the securities directly owned by the Fund. Mr. Ma-Weaver, as the Managing Member of Cable Car, may be deemed to beneficially own the securities directly owned by the Fund.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.